Peter J Barris - Net Worth and Insider Trading

Peter J Barris Net Worth

The estimated net worth of Peter J Barris is at least $2.6 Billion dollars as of 2024-10-05. Peter J Barris is the 10% Owner of Tesaro Inc and owns about 10,422,179 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Peter J Barris is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Peter J Barris is also the 10% Owner of Supernus Pharmaceuticals Inc and owns about 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $247 Million. Besides these, Peter J Barris also holds Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Adaptimmune Therapeutics PLC (ADAP) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Trevi Therapeutics Inc (TRVI) , Senseonics Holdings Inc (SENS) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , GlycoMimetics Inc (GLYC) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Regulus Therapeutics Inc (RGLS) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) . Details can be seen in Peter J Barris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter J Barris has not made any transactions after 2019-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Peter J Barris

Peter J Barris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter J Barris owns 86 companies in total, including Sprout Social Inc (SPT) , Groupon Inc (GRPN) , and Regulus Therapeutics Inc (RGLS) among others .

Click here to see the complete history of Peter J Barris’s form 4 insider trades.

Insider Ownership Summary of Peter J Barris

Ticker	Comapny	Transaction Date	Type of Owner
SPT	Sprout Social Inc	2019-12-12	director & 10 percent owner
GRPN	Groupon Inc	2019-12-26	director & 10 percent owner
RGLS	Regulus Therapeutics Inc	2019-05-07	10 percent owner
		2016-07-18	10 percent owner
		2019-11-26	10 percent owner
		2019-11-06	10 percent owner
		2019-10-30	10 percent owner
		2019-09-12	10 percent owner
		2019-07-22	10 percent owner
		2019-06-24	10 percent owner
		2019-06-07	10 percent owner
		2019-05-09	10 percent owner
		2019-04-08	10 percent owner
		2017-07-03	10 percent owner
		2019-01-22	10 percent owner
		2018-12-14	10 percent owner
		2018-12-07	10 percent owner
		2018-10-17	10 percent owner
		2018-10-17	10 percent owner
		2018-10-04	10 percent owner
		2018-09-07	10 percent owner
		2018-07-30	10 percent owner
		2018-07-24	10 percent owner
		2018-05-10	10 percent owner
		2018-05-01	10 percent owner
		2018-04-23	10 percent owner
		2018-03-27	10 percent owner
		2018-03-09	10 percent owner
		2018-02-26	10 percent owner
		2018-02-26	10 percent owner
		2017-11-27	10 percent owner
		2015-09-30	10 percent owner
		2018-01-01	10 percent owner
		2017-12-08	10 percent owner
		2017-11-20	10 percent owner
		2017-11-06	10 percent owner
		2017-10-10	10 percent owner
		2015-01-26	10 percent owner
		2016-12-19	10 percent owner
		2016-10-11	10 percent owner
		2016-09-21	10 percent owner
		2016-07-29	10 percent owner
		2016-06-14	10 percent owner
		2016-02-03	10 percent owner
		2016-01-12	10 percent owner
		2015-06-17	10 percent owner
		2015-10-14	10 percent owner
		2015-07-01	10 percent owner
		2015-03-11	10 percent owner
		2015-01-22	10 percent owner
		2014-12-19	10 percent owner
		2014-01-30	10 percent owner
		2014-12-02	10 percent owner
		2014-11-25	10 percent owner
		2014-10-08	10 percent owner
		2014-08-27	10 percent owner
		2014-08-06	10 percent owner
		2014-04-02	10 percent owner
		2013-05-22	10 percent owner
		2013-12-05	10 percent owner
		2013-10-29	10 percent owner
		2011-11-21	10 percent owner
		2012-10-11	10 percent owner
		2012-10-29	10 percent owner
		2006-05-23	director & 10 percent owner
		2012-05-30	director
		2012-03-07	10 percent owner
		2012-03-05	director & 10 percent owner
		2011-11-16	director
		2011-08-08	10 percent owner
		2011-03-10	10 percent owner
		2010-08-30	10 percent owner
		2010-06-23	10 percent owner
		2009-05-08	10 percent owner
		2006-05-09	10 percent owner
		2007-08-14	10 percent owner
		2004-02-20	10 percent owner
		2009-04-03	10 percent owner
		2016-02-10	10 percent owner
		2018-12-07	10 percent owner
		2023-07-20	director
		2021-10-28	director
		2022-08-03	director
		2016-02-10	10 percent owner
		2018-01-19	10 percent owner
		2023-07-20	director

Peter J Barris Latest Holdings Summary

Peter J Barris currently owns a total of 34 stocks. Among these stocks, Peter J Barris owns 10,422,179 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 30.4%. Peter J Barris owns 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 16.89%. Peter J Barris also owns 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) as of June 17, 2015, with a value of $247 Million and a weighting of 9.61%. The other 31 stocks Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Adaptimmune Therapeutics PLC (ADAP) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Trevi Therapeutics Inc (TRVI) , Senseonics Holdings Inc (SENS) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , GlycoMimetics Inc (GLYC) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Regulus Therapeutics Inc (RGLS) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) have a combined weighting of 43.1% among all his current holdings.

Latest Holdings of Peter J Barris

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TSRO	Tesaro Inc	2018-03-06	10,422,179	74.96	781,246,538
FNIO	iShares Indl/Office Real Estate Capped	2012-04-30	13,610,551	31.89	434,040,471
SUPN	Supernus Pharmaceuticals Inc	2015-06-17	7,716,055	32.02	247,068,081
RYTM	Rhythm Pharmaceuticals Inc	2017-10-10	4,909,956	49.63	243,681,116
RARX	Ra Pharmaceuticals Inc	2016-10-31	3,490,073	47.99	167,488,603
MIRM	Mirum Pharmaceuticals Inc	2019-07-22	4,186,243	39.26	164,351,900
ARDX	Ardelyx Inc	2016-07-18	14,084,162	6.82	96,053,985
ADAP	Adaptimmune Therapeutics PLC	2018-09-07	94,978,668	0.95	90,324,713
ECHO	Echo Global Logistics Inc	2012-03-05	1,420,901	48.24	68,544,264
WIFI	Boingo Wireless Inc	2013-12-11	4,469,108	13.99	62,522,821
FOLD	Amicus Therapeutics Inc	2012-03-07	5,650,340	10.60	59,893,604
AVEO	AVEO Pharmaceuticals Inc	2019-04-08	2,524,387	15.00	37,865,805
LQDA	Liquidia Corp	2018-07-30	2,484,870	10.03	24,923,246
MRSN	Mersana Therapeutics Inc	2017-07-03	8,140,138	2.12	17,257,093
MM	Millennial Media Inc	2012-10-29	8,196,614	1.75	14,344,075
INWK	InnerWorkings Inc	2012-05-30	4,566,835	2.99	13,654,837
TRVI	Trevi Therapeutics Inc	2019-05-09	4,438,562	3.02	13,404,457
SENS	Senseonics Holdings Inc	2017-12-08	30,936,643	0.34	10,611,269
EPZM	Epizyme Inc	2016-01-12	6,261,599	1.47	9,204,551
DATA	Tableau Software Inc	2014-08-25	40,077	169.53	6,794,254
SURF	Surface Oncology Inc	2018-04-23	3,312,877	1.07	3,544,778
GLYC	GlycoMimetics Inc	2018-05-10	9,089,041	0.16	1,452,429
GRPN	Groupon Inc	2019-12-26	42,476	9.72	412,654
CBIO	Catalyst Biosciences Inc	2013-12-05	43,462	7.67	333,332
RGLS	Regulus Therapeutics Inc	2019-05-07	205,245	1.58	324,287
DERM	Dermira Inc	2014-10-02	17,241	18.75	323,269
ILIU	Interleukin Genetics Inc	2016-07-29	55,418,811	0.00	249,385
AKAOQ	Achaogen Inc	2016-12-19	5,215,128	0.03	130,378
CLVSQ	Clovis Oncology Inc	2011-11-21	3,419,671	0.02	51,295
TCON	TRACON Pharmaceuticals Inc	2018-03-27	17,330	0.13	2,304
GNCAQ	Genocea Biosciences Inc	2019-06-24	7,225,676	0.00	723
NOVCQ	Novation Companies Inc	2006-05-15	1,225,179	0.00	123
ABIO	ARCA biopharma Inc	2018-02-26	0	25.50	0
APPN	Appian Corp	2017-11-27	0	33.83	0

Holding Weightings of Peter J Barris

Peter J Barris Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Peter J Barris around $8 Million.

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 16,101 shares on April 30, 2012, which brought Peter J Barris around $427,160.

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 111,881 shares on June 17, 2015, which brought Peter J Barris around $2 Million.

More details on Peter J Barris's insider transactions can be found in the Insider Trading History of Peter J Barris table.

Insider Trading History of Peter J Barris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter J Barris Trading Performance

GuruFocus tracks the stock performance after each of Peter J Barris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter J Barris is 8.04%. GuruFocus also compares Peter J Barris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter J Barris within 3 months outperforms 25 times out of 48 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter J Barris's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter J Barris

Average Return

Average return per transaction

Outperforming Transactions

12 out of 47 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.76
Relative Return to S&P 500(%)	6.17

Peter J Barris Ownership Network

Ownership Network List of Peter J Barris

No Data

Ownership Network Relation of Peter J Barris

Peter J Barris Owned Company Details

What does Sprout Social Inc do?

Who are the key executives at Sprout Social Inc?

Peter J Barris is the director & 10 percent owner of Sprout Social Inc. Other key executives at Sprout Social Inc include director & 10 percent owner & Chairman and CEO Justyn Russell Howard , President Ryan Paul Barretto , and director & 10 percent owner & Chief Technology Officer Rankin Aaron Edward Frederick .

Sprout Social Inc (SPT) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Sprout Social Inc (SPT). Other recent insider transactions involving Sprout Social Inc (SPT) include a net sale of 42,606 shares made by Preto Joseph Del , a net sale of 523,595 shares made by Justyn Russell Howard , and a net sale of 168,603 shares made by Ryan Paul Barretto .

In summary, during the past 3 months, insiders sold 183,292 shares of Sprout Social Inc (SPT) in total and bought 0 shares, with a net sale of 183,292 shares. During the past 18 months, 952,237 shares of Sprout Social Inc (SPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 952,237 shares.

Sprout Social Inc (SPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sprout Social Inc Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Peter J Barris is the director & 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 4,583 shares of Groupon Inc (GRPN) in total and bought 15,000 shares, with a net purchase of 10,417 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Peter J Barris is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regulus Therapeutics Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Peter J Barris is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include Chief Development Officer David P. Rosenbaum , director & President & CEO Michael Raab , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 247,172 shares made by David P. Rosenbaum , a net sale of 291,827 shares made by Michael Raab , and a net sale of 490,778 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 247,382 shares of Ardelyx Inc (ARDX) in total and bought 0 shares, with a net sale of 247,382 shares. During the past 18 months, 1,881,926 shares of Ardelyx Inc (ARDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,881,926 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Peter J Barris is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Galera Therapeutics Inc do?

Who are the key executives at Galera Therapeutics Inc?

Peter J Barris is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include director & President and CEO Mel Sorensen , Chief Commercial Officer Mark Bachleda , and Chief Financial Officer Chris Degnan .

Galera Therapeutics Inc (GRTX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , and a net sale of 67,015 shares made by Mel Sorensen .

In summary, during the past 3 months, insiders sold 67,015 shares of Galera Therapeutics Inc (GRTX) in total and bought 0 shares, with a net sale of 67,015 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 3,712,809 shares were bought by its insiders, resulting in a net purchase of 3,645,794 shares.

Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Galera Therapeutics Inc Insider Transactions

No Available Data

What does Oyster Point Pharma Inc do?

Who are the key executives at Oyster Point Pharma Inc?

Peter J Barris is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and Chief Commercial Officer John Snisarenko .

Oyster Point Pharma Inc (OYST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oyster Point Pharma Inc Insider Transactions

No Available Data

What does Cloudflare Inc do?

Who are the key executives at Cloudflare Inc?

Peter J Barris is the 10 percent owner of Cloudflare Inc. Other key executives at Cloudflare Inc include Chief Financial Officer Thomas J Seifert , General Counsel Douglas James Kramer , and director & Chief Operating Officer Michelle Zatlyn .

Cloudflare Inc (NET) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Cloudflare Inc (NET). Other recent insider transactions involving Cloudflare Inc (NET) include a net sale of 884,735 shares made by Carl Ledbetter , a net sale of 765,873 shares made by Thomas J Seifert , and a net sale of 2,828,736 shares made by Matthew Prince .

In summary, during the past 3 months, insiders sold 737,257 shares of Cloudflare Inc (NET) in total and bought 0 shares, with a net sale of 737,257 shares. During the past 18 months, 6,209,368 shares of Cloudflare Inc (NET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,209,368 shares.

Cloudflare Inc (NET)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cloudflare Inc Insider Transactions

No Available Data

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include director & 10 percent owner Patrick J Heron , SVP & Global Controller Jolanda Howe , and Chief Scientific Officer Pamela Vig .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net purchase of 162,308 shares made by Patrick J Heron , a net sale of 8,512 shares made by Jolanda Howe , and a net sale of 34,606 shares made by Pamela Vig .

In summary, during the past 3 months, insiders sold 0 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 345 shares, with a net purchase of 345 shares. During the past 18 months, 120,458 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 55,850 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Peter J Barris is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .

Genocea Biosciences Inc (GNCAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Nightstar Therapeutics PLC do?

Who are the key executives at Nightstar Therapeutics PLC?

Peter J Barris is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Scott D Sandell , director & 10 percent owner David M Mott , and 10 percent owner Joshua Makower .

Nightstar Therapeutics PLC (NITE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nightstar Therapeutics PLC Insider Transactions

No Available Data

What does Trevi Therapeutics Inc do?

Who are the key executives at Trevi Therapeutics Inc?

Peter J Barris is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .

Trevi Therapeutics Inc (TRVI) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 9,227 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .

In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 205,946 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,946 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevi Therapeutics Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Mersana Therapeutics Inc do?

Who are the key executives at Mersana Therapeutics Inc?

Peter J Barris is the 10 percent owner of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include director & President and CEO Anna Protopapas , SVP & Chief Development Officer Mohan Bala , and Chief Manufacturing Officer Tushar Misra .

Mersana Therapeutics Inc (MRSN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 8,325 shares made by Alejandra Carvajal , a net sale of 5,343 shares made by Mohan Bala , and a net sale of 5,265 shares made by Tushar Misra .

In summary, during the past 3 months, insiders sold 50,423 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 50,423 shares. During the past 18 months, 123,516 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 123,516 shares.

Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mersana Therapeutics Inc Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Peter J Barris is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Scott D Sandell .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Peter J Barris is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does PhaseBio Pharmaceuticals Inc do?

Who are the key executives at PhaseBio Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .

PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PhaseBio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Peter J Barris is the 10 percent owner of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Scott D Sandell , and 10 percent owner Joshua Makower .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

What does Elastic NV do?

Who are the key executives at Elastic NV?

Peter J Barris is the 10 percent owner of Elastic NV. Other key executives at Elastic NV include Chief Financial Officer Janesh Moorjani , Chief Product Officer Ken Exner , and Chief Legal Officer Carolyn Herzog .

Elastic NV (ESTC) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Elastic NV (ESTC). Other recent insider transactions involving Elastic NV (ESTC) include a net sale of 1,127,578 shares made by Shay Banon , a net sale of 43,532 shares made by Carolyn Herzog , and a net sale of 99,702 shares made by Ashutosh Kulkarni .

In summary, during the past 3 months, insiders sold 42,454 shares of Elastic NV (ESTC) in total and bought 20,000 shares, with a net sale of 22,454 shares. During the past 18 months, 2,270,033 shares of Elastic NV (ESTC) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 2,250,033 shares.

Elastic NV (ESTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elastic NV Insider Transactions

No Available Data

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Peter J Barris is the 10 percent owner of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

Peter J Barris is the 10 percent owner of Liquidia Corp. Other key executives at Liquidia Corp include director & 10 percent owner Paul B Manning , SVP & Commercial Scott Moomaw , and Chief Financial Officer Michael Kaseta .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 11,239 shares made by Jason Adair , a net sale of 12,589 shares made by Scott Moomaw , and a net sale of 28,934 shares made by Rajeev Saggar .

In summary, during the past 3 months, insiders sold 174,584 shares of Liquidia Corp (LQDA) in total and bought 487,078 shares, with a net purchase of 312,494 shares. During the past 18 months, 284,856 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,738,535 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

What does Bloom Energy Corp do?

Who are the key executives at Bloom Energy Corp?

Peter J Barris is the 10 percent owner of Bloom Energy Corp. Other key executives at Bloom Energy Corp include EVP & GC & Secretary Shawn Marie Soderberg , director & Chairman & CEO Kr Sridhar , and EVP & Sales - Americas Guillermo Brooks .

Bloom Energy Corp (BE) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Bloom Energy Corp (BE). Other recent insider transactions involving Bloom Energy Corp (BE) include a net sale of 50,342 shares made by Shawn Marie Soderberg , a net sale of 28,285 shares made by Guillermo Brooks , and a net sale of 17,189 shares made by Sharelynn Faye Moore .

In summary, during the past 3 months, insiders sold 8,417 shares of Bloom Energy Corp (BE) in total and bought 0 shares, with a net sale of 8,417 shares. During the past 18 months, 231,771 shares of Bloom Energy Corp (BE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,771 shares.

Bloom Energy Corp (BE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bloom Energy Corp Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Peter J Barris is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 13,800 shares made by Brian M. Hahn .

In summary, during the past 3 months, insiders sold 2,271,499 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 2,271,499 shares. During the past 18 months, 2,275,199 shares of GlycoMimetics Inc (GLYC) were sold and 431,403 shares were bought by its insiders, resulting in a net sale of 1,843,796 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does MuleSoft Inc do?

Who are the key executives at MuleSoft Inc?

Peter J Barris is the 10 percent owner of MuleSoft Inc. Other key executives at MuleSoft Inc include 10 percent owner Scott D Sandell , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Patrick J Kerins .

MuleSoft Inc (MULE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MuleSoft Inc (MULE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MuleSoft Inc (MULE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MuleSoft Inc (MULE)'s detailed insider trading history can be found in Insider Trading Tracker table.

MuleSoft Inc Insider Transactions

No Available Data

What does Surface Oncology Inc do?

Who are the key executives at Surface Oncology Inc?

Peter J Barris is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .

Surface Oncology Inc (SURF) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surface Oncology Inc Insider Transactions

No Available Data

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. , and a net purchase of 50,999 shares made by Charles Theuer .

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 2,550 shares were bought by its insiders, resulting in a net sale of 235,650 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Peter J Barris is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Jon Sakoda , and 10 percent owner Florence Anthony A. Jr. .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Peter J Barris is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 52,890 shares, with a net purchase of 52,890 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Tintri Inc do?

Who are the key executives at Tintri Inc?

Peter J Barris is the 10 percent owner of Tintri Inc. Other key executives at Tintri Inc include director & Chairman & CEO Kenneth Klein , 10 percent owner Insight Venture Associates Viii, Ltd. , and 10 percent owner Insight Venture Associates Viii, L.p. .

Tintri Inc (TNTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tintri Inc (TNTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tintri Inc (TNTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tintri Inc (TNTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tintri Inc Insider Transactions

No Available Data

What does Appian Corp do?

Who are the key executives at Appian Corp?

Peter J Barris is the 10 percent owner of Appian Corp. Other key executives at Appian Corp include 10 percent owner Abdiel Qualified Master Fund Lp , director & 10 percent owner Biddle Albert G.w. Iii , and Chief Revenue Officer Christopher M Jones .

Appian Corp (APPN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Appian Corp (APPN). Other recent insider transactions involving Appian Corp (APPN) include a net purchase of 57,584 shares made by Abdiel Qualified Master Fund Lp , a net sale of 30,000 shares made by Christopher Winters , and a net sale of 13,068 shares made by Mark Matheos .

In summary, during the past 3 months, insiders sold 0 shares of Appian Corp (APPN) in total and bought 4,289,234 shares, with a net purchase of 4,289,234 shares. During the past 18 months, 4,279,218 shares of Appian Corp (APPN) were sold and 4,300,234 shares were bought by its insiders, resulting in a net purchase of 21,016 shares.

Appian Corp (APPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Appian Corp Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Peter J Barris is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 372 shares made by Antoine Awad , and a net sale of 188 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 560 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 560 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Strongbridge Biopharma PLC do?

Who are the key executives at Strongbridge Biopharma PLC?

Peter J Barris is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .

Strongbridge Biopharma PLC (SBBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Strongbridge Biopharma PLC Insider Transactions

No Available Data

What does Senseonics Holdings Inc do?

Who are the key executives at Senseonics Holdings Inc?

Peter J Barris is the 10 percent owner of Senseonics Holdings Inc. Other key executives at Senseonics Holdings Inc include Chief Financial Officer Frederick T. Sullivan , VP Operations & Qual & Reg Mukul Jain , and VP Global Sales & Marketing Mirasol Panlilio .

Senseonics Holdings Inc (SENS) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Senseonics Holdings Inc (SENS). Other recent insider transactions involving Senseonics Holdings Inc (SENS) include a net purchase of 300,000 shares made by Douglas A Roeder , and a net sale of 30,889 shares made by Sharon Larkin .

In summary, during the past 3 months, insiders sold 0 shares of Senseonics Holdings Inc (SENS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 30,889 shares of Senseonics Holdings Inc (SENS) were sold and 300,000 shares were bought by its insiders, resulting in a net purchase of 269,111 shares.

Senseonics Holdings Inc (SENS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senseonics Holdings Inc Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include Chief Operating Officer Mary Dibiase , Chief Scientific Officer Arthur Taveras , and See Remarks Adam S. Mostafa .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 93,785 shares made by Mary Dibiase , a net sale of 330,550 shares made by Paula Ragan , and a net sale of 321,700 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 2,642 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 2,642 shares. During the past 18 months, 969,065 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 944,065 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Care.com Inc do?

Who are the key executives at Care.com Inc?

Peter J Barris is the 10 percent owner of Care.com Inc. Other key executives at Care.com Inc include 10 percent owner Ac/interactivecorp , 10 percent owner Capitalg Gp Llc , and 10 percent owner Alphabet Inc. .

Care.com Inc (CRCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Care.com Inc (CRCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Care.com Inc (CRCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Care.com Inc (CRCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Care.com Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 191,981 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 191,981 shares. During the past 18 months, 582,666 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 582,666 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Peter J Barris is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Peter J Barris is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Xtera Communications Inc do?

Who are the key executives at Xtera Communications Inc?

Peter J Barris is the 10 percent owner of Xtera Communications Inc. Other key executives at Xtera Communications Inc include 10 percent owner Arch Venture Partners Vi Llc , 10 percent owner Keith Crandell , and 10 percent owner Robert Nelsen .

Xtera Communications Inc (XCOMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xtera Communications Inc (XCOMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xtera Communications Inc (XCOMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xtera Communications Inc (XCOMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xtera Communications Inc Insider Transactions

No Available Data

What does Sorrento Tech Inc do?

Who are the key executives at Sorrento Tech Inc?

Peter J Barris is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Samuel D Isaly , and 10 percent owner Orbimed Advisors Llc .

Sorrento Tech Inc (ROKA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Tech Inc Insider Transactions

No Available Data

What does Interleukin Genetics Inc do?

Who are the key executives at Interleukin Genetics Inc?

Peter J Barris is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner New Enterprise Associates 14, L.p. , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .

Interleukin Genetics Inc (ILIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interleukin Genetics Inc Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

Peter J Barris is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Scott D Sandell , and 10 percent owner M James Barrett .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Peter J Barris is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Peter J Barris is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 13,886 shares made by Georges Gemayel .

In summary, during the past 3 months, insiders sold 13,886 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 13,886 shares. During the past 18 months, 146,329 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 146,329 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Peter J Barris is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 878 shares were bought by its insiders, resulting in a net sale of 14,470 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Peter J Barris is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 75,504 shares made by Daniel Newman Mendelson ,

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 75,504 shares were bought by its insiders, resulting in a net purchase of 75,504 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Champions Oncology Inc Insider Transactions

No Available Data

What does Box Inc do?

Who are the key executives at Box Inc?

Peter J Barris is the 10 percent owner of Box Inc. Other key executives at Box Inc include director & 10 percent owner & Chief Financial Officer Dylan C Smith , director & 10 percent owner & Chief Executive Officer Aaron Levie , and VP Chief Acct Ofr & Controller Eli Berkovitch .

Box Inc (BOX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Box Inc (BOX). Other recent insider transactions involving Box Inc (BOX) include a net sale of 234,000 shares made by Dylan C Smith , a net sale of 60,000 shares made by Aaron Levie , and a net sale of 21,550 shares made by Eli Berkovitch .

In summary, during the past 3 months, insiders sold 70,026 shares of Box Inc (BOX) in total and bought 0 shares, with a net sale of 70,026 shares. During the past 18 months, 498,496 shares of Box Inc (BOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 498,496 shares.

Box Inc (BOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Box Inc Insider Transactions

No Available Data

What does Boingo Wireless Inc do?

Who are the key executives at Boingo Wireless Inc?

Peter J Barris is the 10 percent owner of Boingo Wireless Inc. Other key executives at Boingo Wireless Inc include Chief Technology Officer Derek Peterson , Chief Financial Officer Peter Hovenier , and Chief Marketing Officer Dawn Callahan .

Boingo Wireless Inc (WIFI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Boingo Wireless Inc (WIFI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Boingo Wireless Inc (WIFI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Boingo Wireless Inc (WIFI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Boingo Wireless Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Peter J Barris is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Tableau Software Inc do?

Who are the key executives at Tableau Software Inc?

Peter J Barris is the 10 percent owner of Tableau Software Inc. Other key executives at Tableau Software Inc include EVP & GC & Secretary Keenan Michael Conder , EVP & Product Development Mark Thomas Nelson , and Executive VP & Sales Kelly Wright .

Tableau Software Inc (DATA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tableau Software Inc (DATA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tableau Software Inc (DATA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tableau Software Inc (DATA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tableau Software Inc Insider Transactions

No Available Data

What does Cvent Inc do?

Who are the key executives at Cvent Inc?

Peter J Barris is the 10 percent owner of Cvent Inc. Other key executives at Cvent Inc include Chief Financial Officer Cynthia A Russo , 10 percent owner Insight Venture Partners Vii, L.p. , and 10 percent owner Insight Venture Partners (delaware) Vii, L.p. .

Cvent Inc (CVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cvent Inc (CVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cvent Inc (CVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cvent Inc (CVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cvent Inc Insider Transactions

No Available Data

What does Dermira Inc do?

Who are the key executives at Dermira Inc?

Peter J Barris is the 10 percent owner of Dermira Inc. Other key executives at Dermira Inc include director & Chief Medical Officer Eugene A Bauer , director & CEO & Chairman of the Board Thomas G Wiggans , and CFO Andrew Guggenhime .

Dermira Inc (DERM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dermira Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Peter J Barris is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Aerohive Networks Inc do?

Who are the key executives at Aerohive Networks Inc?

Peter J Barris is the 10 percent owner of Aerohive Networks Inc. Other key executives at Aerohive Networks Inc include VP & Gen. Counsel & Secretary Stephen Debenham , SVP & CFO & COO John Ritchie , and 10 percent owner Lightspeed General Partner Vii, L.p. .

Aerohive Networks Inc (HIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerohive Networks Inc (HIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerohive Networks Inc (HIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerohive Networks Inc (HIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerohive Networks Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

Peter J Barris is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Peter J Barris is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Xoom Corp do?

Who are the key executives at Xoom Corp?

Peter J Barris is the 10 percent owner of Xoom Corp. Other key executives at Xoom Corp include 10 percent owner Capital Xi Sequoia , 10 percent owner Sequoia Technology Partners Xi , and 10 percent owner Sequoia Capital Xi Principals Fund .

Xoom Corp (XOOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xoom Corp (XOOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xoom Corp (XOOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xoom Corp (XOOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xoom Corp Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Peter J Barris is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Peter J Barris is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , Co-President Sayan Chakraborty , and Co-President Douglas A. Robinson .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,095,682 shares made by David A Duffield , a net sale of 30,871 shares made by Douglas A. Robinson , and a net sale of 67,765 shares made by Sayan Chakraborty .

In summary, during the past 3 months, insiders sold 592,206 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 592,206 shares. During the past 18 months, 2,352,499 shares of Workday Inc (WDAY) were sold and 8,676 shares were bought by its insiders, resulting in a net sale of 2,343,823 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Millennial Media Inc do?

Who are the key executives at Millennial Media Inc?

Peter J Barris is the 10 percent owner of Millennial Media Inc. Other key executives at Millennial Media Inc include VP & Controller & Treasurer Lara Sweet , director & President Robert Lord , and 10 percent owner Verizon Communications Inc .

Millennial Media Inc (MM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millennial Media Inc (MM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millennial Media Inc (MM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millennial Media Inc (MM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millennial Media Inc Insider Transactions

No Available Data

What does Vonage Holdings Corp do?

Who are the key executives at Vonage Holdings Corp?

Peter J Barris is the director & 10 percent owner of Vonage Holdings Corp. Other key executives at Vonage Holdings Corp include SVP Corporate Development Vinod Lala , Interim Chief Legal Officer Randy K. Rutherford , and director & Chief Executive Officer Rory P Read .

Vonage Holdings Corp (VG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vonage Holdings Corp (VG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vonage Holdings Corp (VG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vonage Holdings Corp (VG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vonage Holdings Corp Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Peter J Barris is the director of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Peter J Barris is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 345,323 shares made by John F Crowley , a net sale of 229,061 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 812,168 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 812,168 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Peter J Barris is the director & 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does Inteliquent Inc do?

Who are the key executives at Inteliquent Inc?

Peter J Barris is the director of Inteliquent Inc. Other key executives at Inteliquent Inc include director & President and CEO Matthew Jr Carter , Chief Financial Officer / EVP Kurt Abkemeier , and 10 percent owner C Richard Kramlich .

Inteliquent Inc (IQNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inteliquent Inc (IQNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inteliquent Inc (IQNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inteliquent Inc (IQNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inteliquent Inc Insider Transactions

No Available Data

What does Glu Mobile Inc do?

Who are the key executives at Glu Mobile Inc?

Peter J Barris is the 10 percent owner of Glu Mobile Inc. Other key executives at Glu Mobile Inc include EVP & COO and CFO Eric R Ludwig , Senior Vice President & Revenue Becky Ann Hughes , and SVP & Business & Corp. Dev. Chris Akhavan .

Glu Mobile Inc (GLUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Glu Mobile Inc (GLUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Glu Mobile Inc (GLUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Glu Mobile Inc (GLUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glu Mobile Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Peter J Barris is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Financial Engines Inc do?

Who are the key executives at Financial Engines Inc?

Peter J Barris is the 10 percent owner of Financial Engines Inc. Other key executives at Financial Engines Inc include EVP & COO & Pres FE Advisors John Bunch , EVP & CFO Craig L Foster , and other: See footnotes (1)(2)(3)(4) Warburg Pincus Llc .

Financial Engines Inc (FNGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Financial Engines Inc (FNGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Financial Engines Inc (FNGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Financial Engines Inc (FNGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Financial Engines Inc Insider Transactions

No Available Data

What does Voltari Corp do?

Who are the key executives at Voltari Corp?

Peter J Barris is the 10 percent owner of Voltari Corp. Other key executives at Voltari Corp include 10 percent owner Carl C Icahn , Chief Financial Officer Nathan Yu-gai Fong , and SVP & Gen Counsel & Corp Sec Richard Jr Leigh .

Voltari Corp (VLTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Voltari Corp (VLTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Voltari Corp (VLTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Voltari Corp (VLTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voltari Corp Insider Transactions

No Available Data

What does W World Corp do?

Who are the key executives at W World Corp?

Peter J Barris is the 10 percent owner of W World Corp. Other key executives at W World Corp include director & 10 percent owner Anthony B Evnin , director & 10 percent owner Newhall Charles W Iii , and President and CFO Neill Sydney Colin .

W World Corp (WWHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

W World Corp Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does DZS Inc do?

Who are the key executives at DZS Inc?

Peter J Barris is the 10 percent owner of DZS Inc. Other key executives at DZS Inc include Chief Customer Officer & AEMEA Gunter Reiss , Chief Financial Officer Misty Dawn Kawecki , and director & President & CEO Charles D Vogt .

DZS Inc (DZSI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DZS Inc (DZSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DZS Inc (DZSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DZS Inc (DZSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

DZS Inc Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

Peter J Barris is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Peter J Barris is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 14,272 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,272 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 85,728 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Peter J Barris is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Peter J Barris is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 787,999 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 787,999 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does Berkshire Grey Inc do?

Who are the key executives at Berkshire Grey Inc?

Peter J Barris is the director of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .

Berkshire Grey Inc (BGRY) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Berkshire Grey Inc (BGRY). Other recent insider transactions involving Berkshire Grey Inc (BGRY) include a net sale of 65,567,317 shares made by Svf Ii Bg (de) Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,567,317 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,567,317 shares.

Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Berkshire Grey Inc Insider Transactions

No Available Data

What does NextNav Inc do?

Who are the key executives at NextNav Inc?

Peter J Barris is the director of NextNav Inc. Other key executives at NextNav Inc include Corporate Controller Sammaad Shams , SVP & Engineering Arun Raghupathy , and Chief Financial Officer Christian D. Gates .

NextNav Inc (NN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in NextNav Inc (NN). Other recent insider transactions involving NextNav Inc (NN) include a net sale of 47,771 shares made by Sammaad Shams , a net sale of 153,554 shares made by Arun Raghupathy , and a net sale of 128,487 shares made by Christian D. Gates .

In summary, during the past 3 months, insiders sold 3,918 shares of NextNav Inc (NN) in total and bought 250,000 shares, with a net purchase of 246,082 shares. During the past 18 months, 606,391 shares of NextNav Inc (NN) were sold and 1,648,200 shares were bought by its insiders, resulting in a net purchase of 1,041,809 shares.

NextNav Inc (NN)'s detailed insider trading history can be found in Insider Trading Tracker table.

NextNav Inc Insider Transactions

No Available Data

What does ZeroFox Holdings Inc do?

Who are the key executives at ZeroFox Holdings Inc?

Peter J Barris is the director of ZeroFox Holdings Inc. Other key executives at ZeroFox Holdings Inc include director & See Remarks James Christopher Foster , Chief Marketing Officer Prestridge Iii John R , and Chief Technology Officer Michael Morgan Price .

ZeroFox Holdings Inc (ZFOX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in ZeroFox Holdings Inc (ZFOX). Other recent insider transactions involving ZeroFox Holdings Inc (ZFOX) include a net sale of 224,517 shares made by James Christopher Foster , a net sale of 59,691 shares made by Timothy S Bender , and a net sale of 54,174 shares made by Michael Morgan Price .

In summary, during the past 3 months, insiders sold 0 shares of ZeroFox Holdings Inc (ZFOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 515,540 shares of ZeroFox Holdings Inc (ZFOX) were sold and 51,000 shares were bought by its insiders, resulting in a net sale of 464,540 shares.

ZeroFox Holdings Inc (ZFOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ZeroFox Holdings Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Peter J Barris is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 7,250 shares made by Raymond J. Bartoszek , a net purchase of 15,000 shares made by Shawn Iadonato , and a net purchase of 10,000 shares made by Keith Baker .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 50,250 shares were bought by its insiders, resulting in a net purchase of 50,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Peter J Barris is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , EVP PHARM SCI & MFG Stapleton Raymond D Jr , and 10 percent owner Paul Edward Walker .

Genocea Biosciences Inc (GGNNQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Revolution Acceleration Acquisition Corp do?

Who are the key executives at Revolution Acceleration Acquisition Corp?

Peter J Barris is the director of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .

Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Acceleration Acquisition Corp Insider Transactions

No Available Data

Peter J Barris Mailing Address

Above is the net worth, insider trading, and ownership report for Peter J Barris. You might contact Peter J Barris via mailing address: 1119 St Paul Street, Baltimore Md 21202.

Discussions on Peter J Barris

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.